Abstract
Fetoscopic endotracheal occlusion (FETO) is a prenatal treatment that may increase survival in severe congenital diaphragmatic hernia (CDH). In the USA, FETO is offered for isolated severe left-sided CDH in the context of an FDA-approved feasibility study. FETO in non-isolated cases of severe CDH is only performed with a compassionate use exemption from US regulatory bodies. Anomalies frequently associated with CDH include congenital cystic lesions of the lung and cardiac defects. We describe two cases of non-isolated severe left-sided CDH that underwent prenatal FETO, survived after birth and underwent postnatal surgical repair. The potential benefit of FETO in this setting is discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 1046-1049 |
Number of pages | 4 |
Journal | Prenatal Diagnosis |
Volume | 37 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2017 |
ASJC Scopus subject areas
- Genetics(clinical)
- Obstetrics and Gynecology